♟️ Thursday 4 December 2025 Thu, 4 Dec 2025

Ardiden Ltd has completed its merger with Lac Gold, combining two premier Canadian gold projects and raising $10 million to fund upcoming drilling programs. The merger creates a stronger, cash-rich entity poised for growth in Quebec and Ontario.

Pathkey.AI Ltd has announced a pro rata non-renounceable rights issue to raise approximately $920,517, alongside a $2.5 million placement, aiming to fund enhancements to its AI platform and strategic expansion.

Kjerulf David Hastings Ainsworth has initiated an unconditional all-cash proportional takeover offer for 2.9% of Ainsworth Game Technology Ltd shares at $1.30 each, representing a significant premium over recent trading prices and a competing bid by Novomatic.

E79 Gold Mines has completed its acquisition of Cue Metals, gaining control of the Cue Gold Project in Western Australia, while appointing mining veteran Matthew Bowles to its board. The company is set to launch an intensive exploration program starting this December.

Anteris Technologies has secured regulatory green lights for its pivotal PARADIGM trial and raised $25.2 million in capital, advancing its innovative DurAVR® transcatheter heart valve towards commercialisation.

6K Additive has landed a landmark US$27.4 million loan from the US Export-Import Bank, partnering with the Department of War to fund a major expansion in Pennsylvania that will quintuple powder production capacity and create over 50 new jobs.

HITIQ Limited has successfully raised $925,000 through an oversubscribed placement, issuing shares at a discount and attaching listed options to support its concussion management technology's commercialisation.

Volt Resources has initiated a Definitive Feasibility Study for its Alabama Graphite Refinery, aiming to produce high purity graphite by mid-2026 and strengthen US critical minerals supply chains.

Global Lithium Resources has released a Definitive Feasibility Study for its Manna Lithium Project, confirming robust financials and a long mine life in Western Australia. The study sets the stage for a Final Investment Decision in 2026 amid improving lithium market conditions.

FireFly Metals has raised approximately A$139 million to accelerate exploration and development at its Green Bay Copper-Gold Project in Canada, setting the stage for a major resource expansion and a Final Investment Decision in 2026.

Heavy Rare Earths Limited has confirmed significant polymetallic mineralisation at its Prospect Hill Project in South Australia, revealing high-grade silver, copper, zinc, and lead alongside tin. The company plans a maiden drilling program to upgrade South Ridge to a JORC-compliant Mineral Resource Estimate.

Step One Clothing reveals a sharp decline in first-half revenue and a significant EBITDA loss driven by a $10 million inventory write-down, prompting withdrawal of full-year guidance.

Vulcan Energy Resources has raised €398 million through a fully underwritten institutional placement and entitlement offer to fund the construction and commissioning of its Lionheart lithium project, marking a pivotal step from development to execution.

Power Minerals Limited reports robust near-surface niobium and rare earth element assay results from its Santa Anna project in Brazil, setting the stage for a major 10,000m drilling campaign and a maiden resource estimate in early 2026.

Neurizon Therapeutics has completed manufacturing three GMP registration batches of its lead ALS drug candidate NUZ-001 ahead of schedule, paving the way for FDA submissions and clinical trial enrollment.

Island Pharmaceuticals has submitted critical responses to the FDA, advancing the development of its antiviral Galidesivir under the Animal Rule pathway. The company awaits FDA feedback expected by early January 2026, setting the stage for upcoming Marburg virus studies.

Kula Gold Limited’s board unanimously recommends shareholders accept Forrestania Resources’ off-market takeover offer, valuing Kula shares at a significant premium and promising reduced funding risks and exposure to a stronger combined gold portfolio.

Pacific Edge appoints Simon Flood as chairman designate, aiming to leverage his global investment expertise to navigate Medicare reimbursement challenges for its bladder cancer diagnostic tests in the US.